Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol

Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis. Here, we present the protocol of the ImmunoStrong study, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador, Fernando, Lucas-Dato, Ana, Roure, Silvia, Arsuaga, Marta, Pérez-Jacoiste, Asunción, García-Rodríguez, Magdalena, Pérez-Molina, José A., Buonfrate, Dora, Saugar, José María, Molina, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308528/
https://www.ncbi.nlm.nih.gov/pubmed/34199000
http://dx.doi.org/10.3390/pathogens10070812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308528/
https://www.ncbi.nlm.nih.gov/pubmed/34199000
http://dx.doi.org/10.3390/pathogens10070812

Ejemplares similares